BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24121061)

  • 1. Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat.
    Cox BM; Shah MM; Cichon T; Tancer ME; Galloway MP; Thomas DM; Perrine SA
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():229-35. PubMed ID: 24121061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats.
    Shen EY; Ali SF; Meyer JS
    Neuropharmacology; 2011 Dec; 61(8):1183-92. PubMed ID: 21763331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats.
    Stanley N; Salem A; Irvine RJ
    Neuroscience; 2007 Apr; 146(1):321-9. PubMed ID: 17306465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats.
    Walker QD; Williams CN; Jotwani RP; Waller ST; Francis R; Kuhn CM
    Psychopharmacology (Berl); 2007 Jan; 189(4):435-45. PubMed ID: 17019566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram.
    Piper BJ; Fraiman JB; Owens CB; Ali SF; Meyer JS
    Neuropsychopharmacology; 2008 Apr; 33(5):1192-205. PubMed ID: 17609680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat.
    Cassel JC; Riegert C; Rutz S; Koenig J; Rothmaier K; Cosquer B; Lazarus C; Birthelmer A; Jeltsch H; Jones BC; Jackisch R
    Neuropsychopharmacology; 2005 Oct; 30(10):1870-82. PubMed ID: 15785779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate.
    Ali SF; Newport GD; Scallet AC; Binienda Z; Ferguson SA; Bailey JR; Paule MG; Slikker W
    Neurotoxicol Teratol; 1993; 15(2):91-6. PubMed ID: 7685472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats.
    Piper BJ; Ali SF; Daniels LG; Meyer JS
    Synapse; 2010 Jun; 64(6):421-31. PubMed ID: 20169574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors.
    Rodríguez-Arias M; Valverde O; Daza-Losada M; Blanco-Gandía MC; Aguilar MA; Miñarro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():77-84. PubMed ID: 23959085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine.
    Callaghan PD; Farrand K; Salem A; Hughes P; Daws LC; Irvine RJ
    Eur J Pharmacol; 2006 Sep; 546(1-3):74-81. PubMed ID: 16925993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity.
    Bull EJ; Hutson PH; Fone KC
    Neuropharmacology; 2003 Mar; 44(4):439-48. PubMed ID: 12646281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
    Freezer A; Salem A; Irvine RJ
    Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration.
    Reveron ME; Maier EY; Duvauchelle CL
    Behav Brain Res; 2010 Mar; 207(2):500-7. PubMed ID: 19891989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R; Salem A; Irvine RJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.
    Durkin S; Prendergast A; Harkin A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1894-901. PubMed ID: 18824064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats.
    Morley KC; Cornish JL; Li KM; McGregor IS
    Pharmacol Biochem Behav; 2004 Oct; 79(2):331-42. PubMed ID: 15501310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
    Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
    Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys.
    Frederick DL; Ali SF; Slikker W; Gillam MP; Allen RR; Paule MG
    Neurotoxicol Teratol; 1995; 17(5):531-43. PubMed ID: 8551999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of MDMA to ethanol-deprived rats increases ethanol operant self-administration and dopamine release during reinstatement.
    Moreno-Sanz G; O'Shea E; Orio L; Escobedo I; González-Cuevas G; Navarro M; Colado MI; López-Moreno JA
    Int J Neuropsychopharmacol; 2009 Aug; 12(7):929-40. PubMed ID: 19236733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.